Key result
PAD is linked to altered HRV in cardiovascular patients, indicating elevated sympathetic activation.
Why the study?
The influence of peripheral arterial disease on autonomic regulation assessed by heart rate variability in cardiovascular patients was unclear.
Does peripheral arterial disease alter heart rate variability in cardiovascular patients?
Cross-Sectional (n=65)
Does peripheral arterial disease alter heart rate variability in cardiovascular patients?
Peripheral arterial disease alters heart rate variability in cardiovascular patients, suggesting that PAD should be considered when assessing cardiac autonomic regulation for risk stratification.
Answers are grounded in this paper and cite their sources.
May signal autonomic imbalance in PAD; leaves open whether HRV refines risk stratification in cardiovascular patients.
BACKGROUND: Autonomic regulation analysis is useful in risk stratification of ventricular tachycardia and sudden cardiac death in chronic heart failure (CHF). Heart rate variability (HRV) reflects the condition of autonomic regulation. For analyzing the autonomic control the whole cardiovascular system has to be considered. Therefore, the aim of our study was to assess the influence of peripheral arterial disease (PAD) on the autonomic regulation. METHODS: In 53 men (age: 67 +/- 11 years) from the cardiovascular unit we compared standard HRV parameters in 27 with (ankle brachial index, ABI < 0.9) and 26 patients without (ABI >0.9) PAD as well as with 12 healthy subjects as reference. High-resolution electrocardiograms were recorded over 30 minutes under resting conditions. Pulse wave velocity as well as ABI was estimated using the vascular screening system VASERA. RESULTS: In cardiac patients with PAD, we found both significant differences in linear and nonlinear HRV parameters. Higher increase of low-than high-frequency components indicated higher elevated sympathetic than vagal activation. Altered autonomic control can be interpreted as a compensatory mechanism for diminished vascular arteriolar vasodilator capacity in PAD. To maintain the arterial blood pressure, an elevated setpoint of sympathovagal balance is required. CONCLUSIONS: Our data indicate PAD alters the HRV in cardiovascular patients. PAD should be considered in the assessment of cardiac autonomic regulation especially in risk stratification.
No takes yet. Share an insight, caveat, or question.
Goernig et al. (2008) conducted a cross-sectional in Cardiovascular disease and peripheral arterial disease (n=65). Peripheral arterial disease (ABI < 0.9) vs. Cardiovascular patients without PAD (ABI > 0.9) and healthy subjects was evaluated on Standard linear and nonlinear heart rate variability (HRV) parameters. Peripheral arterial disease in cardiovascular patients significantly altered linear and nonlinear heart rate variability parameters, indicating elevated sympathetic activation.
Synapse has enriched 10 related papers. Consider them for comparative context: